As of May 2022 Dicerna Pharmaceuticals has a market cap of $2.97 Billion. This makes Dicerna Pharmaceuticals the world's 3014th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $2.97 B | |
2021 | $2.97 B | 78.42% |
2020 | $1.66 B | 5.85% |
2019 | $1.57 B | 116.24% |
2018 | $0.72 B | 56.37% |
2017 | $0.46 B | 680.22% |
2016 | $0.05 B | -75.55% |
2015 | $0.24 B | -16.55% |
2014 | $0.29 B |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $286.80 B | 9,531.63% | ๐บ๐ธ USA |
![]() Amgen AMGN | $130.94 B | 4,297.46% | ๐บ๐ธ USA |
![]() Merck MRK | $236.11 B | 7,829.44% | ๐บ๐ธ USA |
![]() Regulus Therapeutics RGLS | $0.02 B | -99.03% | ๐บ๐ธ USA |
![]() Alnylam Pharmaceuticals
ALNY | $15.58 B | 423.25% | ๐บ๐ธ USA |
![]() Arrowhead Pharmaceuticals
ARWR | $3.64 B | 22.40% | ๐บ๐ธ USA |